Fair benefits in international medical research

Arras discusses and concurs with the view imparted by Emmanuel and colleagues on the issue of exploitation of host countries in biomedical research. Emmanuel et al. agreed that it is right to be concerned about the exploitation of host country populations, but they insist that the avoidance of exploitation demands fair benefits rather than only reasonable access to successfully developed drugs. However, he disagrees with him and his colleagues' second major claim--that exploitation is a micro level issue separable from larger concerns about global inequity.